| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7084130 | ALCON PHARMS LTD | Intraocular irrigating solution having improved flow characteristics |
Nov, 2021
(2 years ago) | |
Navstel is owned by Alcon Pharms Ltd.
Navstel contains Calcium Chloride; Dextrose; Magnesium Chloride; Oxiglutatione; Potassium Chloride; Sodium Bicarbonate; Sodium Chloride; Sodium Phosphate.
Navstel has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Navstel are:
- US7084130
Navstel was authorised for market use on 24 July, 2008.
Navstel is available in solution;irrigation dosage forms.
Navstel can be used as use as an intraocular irrigating solution during surgical procedures involving perfusion of the eye.
The generics of Navstel are possible to be released after 29 November, 2021.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Product(NP) | Jul 24, 2011 |
Market Authorisation Date: 24 July, 2008
Treatment: Use as an intraocular irrigating solution during surgical procedures involving perfusion of the eye
Dosage: SOLUTION;IRRIGATION
NAVSTEL family patents
